Precocious puberty in narcolepsy type 1: Orexin loss and/or neuroinflammation, which is to blame?

Sleep Med Rev. 2022 Oct:65:101683. doi: 10.1016/j.smrv.2022.101683. Epub 2022 Sep 10.

Abstract

Narcolepsy type 1 (NT1) is a rare neurological sleep disorder triggered by postnatal loss of the orexin/hypocretin neuropeptides. Overweight/obesity and precocious puberty are highly prevalent comorbidities of NT1, with a close temporal correlation with disease onset, suggesting a common origin. However, the underlying mechanisms remain unknown and merit further investigation. The main question we address in this review is whether the occurrence of precocious puberty in NT1 is due to the lack of orexin/hypocretin or rather to a wider hypothalamic dysfunction in the context of neuroinflammation, which is likely to accompany the disease given its autoimmune origins. Our analysis suggests that the suspected generalized neuroinflammation of the hypothalamus in NT1 would tend to delay puberty rather than hastening it. In contrast, that the brutal loss of orexin/hypocretin would favor an early reactivation of gonadotropin-releasing hormone (GnRH) secretion during the prepubertal period in vulnerable children, leading to early puberty onset. Orexin/hypocretin replacement could thus be envisaged as a potential treatment for precocious puberty in NT1. Additionally, we put forward an alternative hypothesis regarding the concomitant occurrence of sleepiness, weight gain and early puberty in NT1.

Keywords: Autoimmunity; GnRH; Hypocretin; Hypothalamic-pituitary-gonadal axis; Hypothalamus; Neuroendocrine axes; Orexin.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Gonadotropin-Releasing Hormone
  • Humans
  • Narcolepsy*
  • Neuroinflammatory Diseases
  • Neuropeptides*
  • Orexins
  • Puberty, Precocious* / complications

Substances

  • Neuropeptides
  • Orexins
  • Gonadotropin-Releasing Hormone